Cargando…
Hyperoxia during venoarterial ECMO: Culprit or co-variate? A comment from the BLENDER investigators
Autores principales: | Premraj, Lavienraj, Brown, Alastair, Burrell, Aidan, Fraser, John F., Pilcher, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644601/ https://www.ncbi.nlm.nih.gov/pubmed/36348428 http://dx.doi.org/10.1186/s13054-022-04213-8 |
Ejemplares similares
-
Hyperoxia in patients on venoarterial extracorporeal membrane oxygenation
por: Li, Chenglong, et al.
Publicado: (2022) -
The stroke care puzzle: Does tracheostomy timing fit?
por: Camarda, Christopher, et al.
Publicado: (2023) -
Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) Trial: Study Protocol and Statistical Analysis Plan
por: Burrell, Aidan, et al.
Publicado: (2023) -
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
por: Winiszewski, Hadrien, et al.
Publicado: (2022) -
COVID-19 and ECMO: a call for close cooperation and more investigation
por: Lorusso, Roberto, et al.
Publicado: (2021)